These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27806086)

  • 21. Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model.
    Abe S; Kaneko MK; Tsuchihashi Y; Izumi T; Ogasawara S; Okada N; Sato C; Tobiume M; Otsuka K; Miyamoto L; Tsuchiya K; Kawazoe K; Kato Y; Nishioka Y
    Cancer Sci; 2016 Sep; 107(9):1198-205. PubMed ID: 27294401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells.
    Pattarozzi A; Carra E; Favoni RE; Würth R; Marubbi D; Filiberti RA; Mutti L; Florio T; Barbieri F; Daga A
    Stem Cell Res Ther; 2017 May; 8(1):119. PubMed ID: 28545562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.
    Zanellato I; Colangelo D; Osella D
    Curr Cancer Drug Targets; 2018; 18(8):816-828. PubMed ID: 28669341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The platinum (II) complex [Pt(O,O'-acac)(γ-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells.
    Muscella A; Calabriso N; Vetrugno C; Fanizzi FP; De Pascali SA; Storelli C; Marsigliante S
    Biochem Pharmacol; 2011 Jan; 81(1):91-103. PubMed ID: 20854797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.
    Hoda MA; Mohamed A; Ghanim B; Filipits M; Hegedus B; Tamura M; Berta J; Kubista B; Dome B; Grusch M; Setinek U; Micksche M; Klepetko W; Berger W
    J Thorac Oncol; 2011 May; 6(5):852-63. PubMed ID: 21358348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma.
    Katz SI; Zhou L; Chao G; Smith CD; Ferrara T; Wang W; Dicker DT; El-Deiry WS
    Cancer Biol Ther; 2009 Dec; 8(24):2406-16. PubMed ID: 20038816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition.
    Quispel-Janssen JM; Badhai J; Schunselaar L; Price S; Brammeld J; Iorio F; Kolluri K; Garnett M; Berns A; Baas P; McDermott U; Neefjes J; Alifrangis C
    Clin Cancer Res; 2018 Jan; 24(1):84-94. PubMed ID: 29061644
    [No Abstract]   [Full Text] [Related]  

  • 28. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
    Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC
    Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical investigation of folate receptor-targeted nanoparticles for photodynamic therapy of malignant pleural mesothelioma.
    Kato T; Jin CS; Lee D; Ujiie H; Fujino K; Hu HP; Wada H; Wu L; Chen J; Weersink RA; Kanno H; Hatanaka Y; Hatanaka KC; Kaga K; Matsui Y; Matsuno Y; De Perrot M; Wilson BC; Zheng G; Yasufuku K
    Int J Oncol; 2018 Nov; 53(5):2034-2046. PubMed ID: 30226590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway.
    Muscella A; Vetrugno C; Calabriso N; Cossa LG; De Pascali SA; Fanizzi FP; Marsigliante S
    PLoS One; 2014; 9(11):e112186. PubMed ID: 25372487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pt(O,O'-acac)(γ-acac)(DMS)]: Alternative Strategies to Overcome Cisplatin-Induced Side Effects and Resistance in T98G Glioma Cells.
    Astesana V; Faris P; Ferrari B; Siciliani S; Lim D; Biggiogera M; De Pascali SA; Fanizzi FP; Roda E; Moccia F; Bottone MG
    Cell Mol Neurobiol; 2021 Apr; 41(3):563-587. PubMed ID: 32430779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of MEK and PI3K inhibitors against malignant pleural mesothelioma cells in vitro and in vivo.
    Miyoshi S; Hamada H; Hamaguchi N; Kato A; Katayama H; Irifune K; Ito R; Miyazaki T; Okura T; Higaki J
    Int J Oncol; 2012 Aug; 41(2):449-56. PubMed ID: 22580933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pt(O,O'-acac)(γ-acac)(DMS)] versus cisplatin: apoptotic effects in B50 neuroblastoma cells.
    Grimaldi M; Santin G; Insolia V; Dal Bo V; Piccolini VM; Veneroni P; Barni S; Verri M; De Pascali SA; Fanizzi FP; Bernocchi G; Bottone MG
    Histochem Cell Biol; 2016 May; 145(5):587-601. PubMed ID: 26748644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manumycin A induces apoptosis in malignant pleural mesothelioma through regulation of Sp1 and activation of the mitochondria-related apoptotic pathway.
    Kim KH; Chae JI; Oh H; Cho JH; Lee RH; Yoon G; Cho SS; Cho YS; Lee MH; Liu K; Lee HJ; Shim JH
    Oncol Rep; 2016 Jul; 36(1):117-24. PubMed ID: 27176604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion.
    Pulito C; Mori F; Sacconi A; Casadei L; Ferraiuolo M; Valerio MC; Santoro R; Goeman F; Maidecchi A; Mattoli L; Manetti C; Di Agostino S; Muti P; Blandino G; Strano S
    Oncotarget; 2015 Jul; 6(20):18134-50. PubMed ID: 26136339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unsymmetric Cisplatin-Based Pt(IV) Conjugates Containing a PARP-1 Inhibitor Pharmacophore Tested on Malignant Pleural Mesothelioma Cell Lines.
    Gabano E; Pinton G; Balzano C; Boumya S; Osella D; Moro L; Ravera M
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.
    Shapiro IM; Kolev VN; Vidal CM; Kadariya Y; Ring JE; Wright Q; Weaver DT; Menges C; Padval M; McClatchey AI; Xu Q; Testa JR; Pachter JA
    Sci Transl Med; 2014 May; 6(237):237ra68. PubMed ID: 24848258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
    Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
    J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADP sensitizes ZL55 cells to the activity of cisplatin.
    Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
    J Cell Physiol; 2019 Apr; 234(4):4409-4417. PubMed ID: 30144378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.